Inbiomotion

Inbiomotion

Pre-clinical
Barcelona, SpainFounded 2010inbiomotion.com

Breast cancer is the most commonly diagnosed cancer for women, and still remains the leading cause of cancer death in women worldwide. Most deaths are due to metastatic spread rather than to the primary tumor.Currently there is a growing unmet need for biomarkers for effective patient management to identify patients that will benefit an adjuvant treatment to prevent disease spread.

Founded
2010
Focus
Diagnostics

About

Breast cancer is the most commonly diagnosed cancer for women, and still remains the leading cause of cancer death in women worldwide. Most deaths are due to metastatic spread rather than to the primary tumor.Currently there is a growing unmet need for biomarkers for effective patient management to identify patients that will benefit an adjuvant treatment to prevent disease spread.

Funding History

2

Total raised: $25M

Series B$15MKurma PartnersMar 15, 2021
Series A$10MYsios CapitalSep 15, 2018

Company Info

TypePrivate
Founded2010
LocationBarcelona, Spain
StagePre-clinical
SIMILAR COMPANIES
A4Cell
A4Cell
Pre-clinical · Barcelona
Ability Pharma
Ability Pharma
Phase 2 · Barcelona
Abyntek Biopharma
Abyntek Biopharma
Pre-clinical · Derio
Acellera
Acellera
Pre-clinical · Barcelona
BeCytes Biotechnologies
BeCytes Biotechnologies
Pre-clinical · Barcelona
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile